Efficacy of HUEXC030 in Subjects With Pulmonary Tuberculosis
Condition(s):Pulmonary TuberculosisLast Updated:June 15, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Pulmonary TuberculosisLast Updated:June 15, 2022Completed
Condition(s):Tuberculosis, Pulmonary, Drug Sensitive; Tuberculosis, Pulmonary, Multi Drug-resistantLast Updated:March 26, 2019Completed
Condition(s):Tuberculosis; HIV-1-infection; Immuno-DeficiencyLast Updated:September 21, 2022Recruiting
Condition(s):Multi-drug Resistant TuberculosisLast Updated:July 27, 2021Unknown status
Condition(s):Tuberculosis; Aids; Hiv InfectionsLast Updated:February 15, 2012Completed
Condition(s):TuberculosisLast Updated:December 14, 2023Active, not recruiting
Condition(s):Pulmonary TuberculosisLast Updated:December 8, 2023Recruiting
Condition(s):Mycobacterium Avium-intracellulare Infection; HIV InfectionsLast Updated:November 4, 2021Completed
Condition(s):Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TBLast Updated:September 10, 2019Completed
Condition(s):MDR-TBLast Updated:September 28, 2023Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.